Latest updates for Azn

Fresh curated links around AZN are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC
  • AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B
  • ANC

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 week ago

AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC

AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney d...

Read source
genengnews.com /1 day ago

AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B

Dizal has been pursuing approvals from the FDA and China’s Center for Drug Evaluation (CDE) for a new indication for Zegfrovy, as a first-line treatment for NSCLC with exon 20 inse...

Read source
cafepharma.com /1 month ago

ANC

ANC Anonymous (not verified) Thu, 06/04/2026 - 17:44 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...

Read source
fiercebiotech.com /2 weeks ago

AstraZeneca unveils phase 3 bone disease data behind $5B forecast for Strensiq successor

AstraZeneca has shared the data behind previously disclosed phase 3 rare disease wins, fleshing out the case for a Strensiq successor tipped to generate blockbuster sales. The comp...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Azn

cafepharma.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source